24小时热门版块排行榜    

CyRhmU.jpeg
南方科技大学公共卫生及应急管理学院2026级博士研究生招生报考通知(长期有效)
查看: 1010  |  回复: 10
当前主题已经存档。

cpucqzj

[交流] 【原创】对康涅狄格大学了解的朋友看过来(有40金币奉送)!!

各位对康涅狄格大学了解的大侠,请帮忙
这几天老板打算帮我推荐到康涅狄格大学做博后
但我对该校尤其是目标导师知之甚少,毕竟又是老板介绍的,如果贸然答应想不去就不好了,但也不能拖太久,总要给他个答复的。
先不说废话了,把目标老板信息贴上来吧 大家帮我拿个主意
Diane J. Burgess
Ph.D.
Board of Trustees Distinguished Professor
Professor of Pharmaceutics
University of Connecticut
School of Pharmacy
虽然据说发过100篇以上文章,但大多在3-5分之间,最高的6.5,也有很多2分以下的,头衔好像挺多,是什么特聘教授什么协会主席什么药典委员会生物制药评审专家等,拿过两次校优秀教师奖。我总觉得她侧重于教学和行政,要不然应该有10分以上的文章出来的。
她的方向和我的很吻合,是做高分子药物载体的,研究界面化学,药物控释等,如果去了,就不用为工作和各种申请烦心,只是去了如果没有很好的平台发点牛的paper,也是不太值得的。本人现在又三篇3.0以上文章,journal of controlled release, nanotechnology, pharmaceutical research. 总觉得我在国内已经有5分的文章了,再到国外辛辛苦苦还是很难发7分以上的文章,总觉得有点不情愿,但是这毕竟是机会,现在出国也是很烦而且也不容易找到太牛的实验室。我很愁,请大家帮忙。
(以下是她的详细情况,请热心大侠略看,谢谢!!)

Diane J. Burgess
Ph.D.
Board of Trustees Distinguished Professor
Professor of Pharmaceutics

University of Connecticut
School of Pharmacy, Room 432
69 North Eagleville Road, Unit 3092
Storrs, Connecticut 06269-3092

Phone: (860) 486-3760
Fax: (860) 486-2076
E-Mail: d.burgess@uconn.edu

Educational Background
◊  Postdoctural Research, Universities of Amsterdam, Nottingham, and North Carolina   
◊ Ph.D., University of London, United Kingdom     
◊ B.Sc., University of Strathclyde, Glasgow, United Kingdom
     
Professional Accomplishments

Dr. Burgess was the recipient of the Outstanding Teacher of the Year Award (2005 and 1992).  She was the 2002 President of the American Association of Pharmaceutical Scientists (AAPS) and is an AAPS fellow.  She was recently elected Vice President of the Controlled Release Society and will be the 2009-2010 President.  She is currently a member of the USP Biopharmaceuticals Expert committee and is a member of the USP Advisory Panel on Injectables.  Dr. Burgess was an editor for AAPSharmsci (1999-2005) and is editor of the Journal of Drug Delivery Science and Technology (2003-present) and serves on the editorial boards of: the Journal of Pharmacy and pharmacology (1997-present); the Journal of Microencapsulationi (1997-present); Crital Reviewers in Therapeutic Drug Carrier Systems (2004-present); the International Journal of Pharmaceutics (2004-present); and the Journal of Diabetes Science and Technology (2006-present).  In 2001 she underook a sabbatical leave at the Office of Testing and Research at CDER, FDA.  She consults for pharmaceutical, food, cosmetic and other engineering industries on issues related to dispersed systems, in vitro release testing, IVIVC, interfacial chemistry and particle size analysis.

Professional Interests

Dr. Burgess runs a multidisciplinary laboratory.  Research efforts focus on drug delivery systems, in particular, nonoparticles, microspheres, emulsions, liposomes, hydrogels, and novel coatings for implantable devises as well as interfacial chemistry.  Research interests include small molecule drugs, proteins, peptides and DNA therapeutics.  Together with faculty in Chemistry (Dr. Fotios Papadimitrakopoulos) and Electrical Engineering (Dr. Faquir Jain), Dr. Burgess is developing a miniaturized, implantable biosensor for metabalic monitoring.  The team is developing an implantable coating to control tissue response to implantable devices.  Drs. Burgess and Papidimitrakopoulos are using quantum dots to investigate intracellular traficking of DNA therapeutics and vectors.  Dr. Burgess' group is developing in vitro performance tests for controlled release parenterals products and has collaborations with both the Food and Drug Association (FDA) and the United States Pharmacopeia (USP).  This work includes evaluation of in vitro and in vivo correlation (IVIVC) of controlled release parenterals and development of appropriate in vitro release testing methods.  Other important research areas are investigation of both nanoparticle and emulsion stability using a variety interfacial techniques and particle size analysis.

Selected Recent Publications (out of over 100 publications)  
1.  B.S. Zolnik, and D.J. Burgess*.  Evaluation of In vivo - In vitro Release of Dexamethasome from PLGA Microspheres. J. Controlled Release 2008 (127) 137-145.
   
2.  U. Bhardwaj, R. Sura, F. Papadimitrakopoulos, and D.J. Burgess*.  Controlling Acute Inflammation with fast-releasing dexamethasone PLGA microsphere/PVA hydrogel composites for implantable devices.  Journal of Diabetes Science and Technology 2007, 1(1) 8-17.
   
3.  S.D. Patil, F. Papidimitrakopoulos, and D.J. Burgess*.  Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J. Controlled Release 2007, 117(1) 68-79.
   
4.  C. Srinivasan, J. Lee, F. Papadimitrakopoulos, L.K. Silbart, M.H. Zhao and D.J. Burgess*.  Labeling and intracellular tracking of functionally active plasmid DNA with semiconductor quantum dots.  Molecular Therapy 2006, 14(2) 192-201.
   
5.  S.D. Patil, D.G. Rhodes, and D.J. Burgess*.  Bio-physical characterization of a novel anionic liposomal delivery system.  Biochimica et Biophysica Acta. 2005; 1711(1):1-11.
  Top ten most downloaded articles of 2005 in BBA.
   
6.  S.D. Patil, D.G. Rhodes and D.J. Burgess*.  DNA-based therapeutics and their delivery systems: A comprehensive review.  The AAPS J. 2005;7(1):article 9.
  2007 Outstanding Manuscript Award, The AAPS Journal
   
7.  S.D. Patil, D.G. Rhodes and D.J. Burgess*.  Anionic liposomal delivery system for DNA transfection.  The AAPS J. 2004:6(4);article 29.
   
8.  J. Jiao and D.J. Burgess*.  Ostwald ripening of water-in-hydrocarbon emulsions.  J. Coll. Interface Sci. 2003;264(2):506-516.
回复此楼
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

travelerchem

至尊木虫 (知名作家)

★ ★
cpucqzj(金币+2,VIP+0): 10-27 08:21
薰衣草儿(金币+0,VIP+0):欢迎讨论~ 10-27 10:51
如果自己联系不到更好的导师或是实验室,还是可以考虑去那边做的。
2楼2009-10-26 23:41:39
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

hxp207

木虫 (著名写手)

★ ★ ★ ★ ★ ★ ★ ★ ★ ★ ★
cpucqzj(金币+5,VIP+0): 10-27 08:20
cpucqzj(金币+5,VIP+0):请问你现在还和你同学联系吗 能不能提供他的联系方式 我急用的 谢谢啊 10-27 08:21
薰衣草儿(金币+1,VIP+0):欢迎讨论~ 10-27 10:50
一个同学在那里,在美国东部,自然环境很不错,学校几乎就在森林里。气候四季分明,物价,消费要高一些。
3楼2009-10-27 07:50:56
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

mryingzi

铁虫 (小有名气)

★ ★ ★
cpucqzj(金币+3,VIP+0):谢谢!! 10-28 08:11
不错的学校 其实如果是推荐的话 可以先去 然后在找机会跳到更好的学校了
关键是先去那里 才有比较大的机会跳
认识一个人去了100以外的一个烂校做博后做了1年不到,跳到了TOp10的学校
楼主还是要抓住机会了,现在找博后职位还是挺难找的,有机会可以先占个坑了
4楼2009-10-27 19:09:10
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

mryingzi

铁虫 (小有名气)

★ ★ ★ ★ ★ ★ ★ ★ ★ ★
cpucqzj(金币+10,VIP+0):是吗?在IJP的官方网页能看到吗?请问你还有什么好的信息吗? 11-1 18:17
最近发现这个人是IJP的副主编 应该也小有名气吧
5楼2009-11-01 15:52:16
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

mryingzi

铁虫 (小有名气)

★ ★
cpucqzj(金币+2,VIP+0):谢谢你提供的宝贵信息 11-2 08:17
在IJP的editor board 那里可以看到 他是负责美国、澳大利亚和新西兰稿件的
这个人应该不错,能做到IJP的副主编应该很好了
6楼2009-11-01 19:10:07
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

aegeansyang

银虫 (正式写手)

★ ★ ★ ★
cpucqzj(金币+4,VIP+0):谢谢评价,我的信心也是越来越大了 11-3 23:53
而且曾是AAPS的主席. 这个已经算蛮牛的了. 制药的也就是这些杂志啊...都在3-5分左右. JCR, PHARM RES, MOLECULAR PHARMACEUTICS, JPET, GENE THERAPY, MOLECULAR THERAPY, BIOMATERIALS....但都是主流杂志啊, 你牛也可以发PNAS之类 的.
7楼2009-11-03 19:08:13
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

zoujie

铁杆木虫 (职业作家)

先去占个坑,以后还可以往好地方跳吗
8楼2009-11-11 17:04:27
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

xhyu2936

金虫 (初入文坛)


薰衣草儿(金币+1,VIP+0):欢迎讨论~ 11-13 09:30
Fotios Papadimi, 估计他的publication 比较对你的胃口。
不过话说回来,金子到那里都能发光。你挑老板这么picky, 不知道!
9楼2009-11-12 08:07:29
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖

stent

金虫 (著名写手)

★ ★ ★ ★ ★
薰衣草儿(金币+2,VIP+0):欢迎讨论~ 11-13 09:30
cpucqzj(金币+3,VIP+0): 11-14 01:04
不能光看影响因子的,还要看她的文章在这个领域的影响力,比如被引用的次数、提出的理论对别人的影响、设计的试验方法对别人的影响什么的。例如某人灌水了一篇nature,但后来基本没人注意过这篇文章,这又有什么意思呢?有些领域的期刊影响因子整体不太高,lz要从长远考虑,不能盯着IF不放,还需要综合考虑。其实我觉得虽然对老师不了解,但学校还不错,周围的科研氛围也许会很好,这就有很大的机会接触到牛。
10楼2009-11-12 20:34:48
已阅   回复此楼   关注TA 给TA发消息 送TA红花 TA的回帖
相关版块跳转 我要订阅楼主 cpucqzj 的主题更新
普通表情 高级回复(可上传附件)
信息提示
请填处理意见